UK-based Bespak, one of the two contract manufacturers of Pfizer's
inhaled insulin Exubera, confirmed on Friday it has been approached
by a potential buyer.
Netherlands-based DSM has invested an undisclosed sum in Danish
purification technology company Upfront Chromatography to boost its
protein separation business.
Catalent Pharma Solutions, the firm born from the spin out of
Cardinal Health's contract manufacturing business, is reorganising
its production facilities with an expansion of its UK site and the
divestiture of some of its French...
Swiss supplier and services provider Lonza has added another
product to its catalogue of cell culture media, the most recent
addition to the offering of its new bioscience unit.
Applied Biosystems (ABI) has successfully protected more of its PCR
(polymerase chain reaction) patents with Agilent agreeing to
license its thermal cycler technology.
Chinese drug manufacturers could be given a 24-hour deadline by
regulators to pull unsafe pharmaceuticals off the market or face a
fine, a Chinese newspaper reported.
ProMetic's purification technology has been implemented in a
large-scale biomanufacturing process with an undisclosed client for
a product that will be used in clinical trials.
Novartis and Bayer Schering Pharma have finally settled their
disputes over multiple sclerosis (MS) drug Betaseron (interferon
beta-1b), with an agreement outlined in March now complete.
ZS Genetics has signed up outside academic assistance to speed
up development of its 'revolutionary' microscopy-based genetic
analysis technology platform.
Wyeth has signed a license agreement with French firm Flamel
Technologies to apply the company's second innovative drug delivery
technology to one of its protein therapeutics.
Industrial microbiology expert bioMerieux has acquired Australian
firm BTF, strengthening its quality control (QC) and manufacturing
quality assurance (QA) offerings to the pharmaceutical industry.
A new TEM (transmission electron microscope) developed by the TEAM
project has achieved 'the highest resolution images ever recorded'
using the technique.
Vivalis is set to stamp out the Chinese Hamster Ovary (CHO) cell
line competition as the French company announces initial results in
a second study on monoclonal antibody production using its
avian-derived cell line.
Enzo Biochem has lodged an appeal after its patent infringement
claims against Applied Biosystems (ABI) were dismissed on Friday in
a summary judgement.
It appears that pharma heavyweight Pfizer has not emerged unscathed
from the contamination chaos that has affected EU supplies of HIV
drug Viracept (nelfinavir), with the company this week warning that
its version of the treatment...
It seems that the ghost of the US Food and Drug Administration
(FDA) probe has stopped haunting MDS Pharma as the firm posted
encouraging financial results in the third quarter.
AstraZeneca (AZ) is to assist Biovator in the development of its
in vitro test for identifying potential allergens that
could replace many experiments on animals.
German firm Biotest has bought up Nabi Biopharmaceuticals biologics
division in a multi-million Euro deal, less than three months after
the unit was created following Nabi restructuring efforts.
Denmark-based Chr. Hansen has sold its excipients and coating
division to US company Colorcon for an undisclosed sum to
concentrate on its food business.
Anasys Instruments has launched the world's first easy-to-use local
thermal analyser which promises to help pharmaceutical companies'
quality control (QC) of drug coatings and formulations.
French pharmaceutical firm LFB has announced its plans to
incrementally acquire fellow biotech company MAbgene through
the development of a new entity for a total of €6m.
US biopharmaceutical company CytoGenix has announced breaking
ground on a new $3.8m facility to expand the company's
manufacturing capability of synthetic DNA.
Britain's Eden Biodesign has been selected by Cancer Research UK as
the beneficiary of two new biomanufacturing contracts as its
biomanufacturing business continues to grow.
Acambis has had its smallpox vaccine approved by the US, coming one
step closer to closing another supply contract for the US Strategic
National Stockpile.
The end of the tunnel seems to be getting closer for South
African manufacturer Enaleni as the firm confirmed it will resume
production in its recently closed Durban facility in the next ten
days.
US researchers have shown certain organic solvents can be used to
selectively extract therapeutic proteins from host bacteria,
avoiding the need for cell lysis and increasing product purity by a
factor of five.
Reformulations of pseudoephedrine- and ephedrine-containing drugs
in the UK look unlikely following the announcement of less extreme
restrictions on the sale of the pharmaceuticals.
LabTechnologist.com brings you its periodic round up of new product
releases and product news, with new offerings from Aura, Horiba
Jobin Yvon, Integra, Metrohm, Millipore, Promega, Roche and Thermo
Fisher Scientific.
In the latest phase of growth at chemical firm SAFC's flagship high
potency active pharmaceutical ingredients (HPAPIs) facility in
Madison, Wisconsin, the site will be treated to another
multi-million dollar expansion and new...
Sigma-Aldrich has launched a new technology that promises to
dramatically simplify and speed-up high-throughput (HT) RNAi
screening of the human kinome.
Lonza's $200m (€147m) investment in China is continuing to shape up
as the firm announced its new small-scale exclusive synthesis
manufacturing plant will be up and running next month.
ALK-Abello will be funding a new DKK 300m (€40.3m) production line
dedicated to its oral grass pollen allergy vaccine at Catalent
Pharma Solutions' UK facility.
Novartis last week began construction of a major new flu vaccine
manufacturing facility in North Carolina, the very first cell
culture-derived flu vaccine plant in the United States.
A new device has been developed enabling researchers to study the
stability of therapeutic proteins against shear stresses to allow
better bioprocess optimisation.
Symyx Technologies has released a machine designed to automate the
sample preparation stage of active pharmaceutical ingredient (API)
solubility experiments, saving researchers valuable time.
Adams Respiratory Therapeutics is positive about its plans to build
its prescription products portfolio after announcing its financial
results for the 2007 fourth quarter and year-end.
The Medical House (TMH) has sold its SQ-PEN needle-free insulin
injector business as it moves away from supplying the product to
private individuals to focus more on its drug delivery systems
business.
Solvay Pharmaceuticals still believed it was on track for meeting
US regulatory deadlines for pancreatic insufficiency drugs despite
receiving an approvable letter for its own newly formulated drug
Creon.
Danish diabetes care specialist Novo Nordisk has expanded an
agreement with biotech supplier Millipore, granting exclusive,
long-term distribution rights to the company's insulin
products for cell culture applications.
Pfizer was taken by surprise this week as a US engineering firm
announced that it had been awarded a contract to manage
construction of the firm's proposed biotech production plant in
Ireland, before the plant plans themselves...
A US scientist says he has fulfilled his dream by creating the
first 3D images of a living cell, finally allowing researchers to
study them in their natural state.
